Axla stock forecast.

AXA1125 is a novel composition of EMMs designed to simultaneously support metabolic, inflammatory and fibrotic pathways associated with fatigue. Axcella was previously granted patents related to ...

Axla stock forecast. Things To Know About Axla stock forecast.

The share price of Knightscope, Inc. Class A (KSCP) now. What analysts predict: $3.75. 52-week High/Low: $2.55 / $0.36. 50/200 Day Moving Average: $0.752 / $0.863. This figure corresponds to the Average Price over the previous 50/200 days. For Knightscope stocks, the 50-day moving average is the resistance level today.Short Borrow Fee Rates. AXLA / Axcella Health Inc short borrow fee rates are shown in the following table. This table shows the interest rate that must be paid by a short seller of US:AXLA to the lender of that security. This fee is shown as …Star Bulk Carriers (NASDAQ:SBLK) pays an annual dividend of $1.60 per share and currently has a dividend yield of 7.88%. SBLK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 74.07%. This payout ratio is at a healthy, sustainable level, below 75%.WebExxe Group saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 5,000 shares, an increase of 900.0% from the October 15th total of 500 shares. Based on an average trading volume of 17,274,200 shares, the short-interest ratio is presently 0.0 days.

4 Wall Street research analysts have issued twelve-month price objectives for Ginkgo Bioworks' shares. Their DNA share price targets range from $1.25 to $3.00. On average, they anticipate the company's stock price to reach $2.25 in the next year. This suggests a possible upside of 58.5% from the stock's current price.Web

It’s likely that AXLA’s strong stock movement this morning is the result of it being a penny stock. That comes from its low trading price of 18 cents and its market capitalization of only $12. ...

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...But as . Axcella Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst …Jaguar Health, Inc. (NASDAQ:JAGX) released its quarterly earnings data on Wednesday, November, 17th. The biotechnology company reported ($0.27) EPS for the quarter, missing the consensus estimate of ($0.18) by $0.09. The biotechnology company earned $0.63 million during the quarter.Oct 15, 2020 · Axcella Health (AXLA) stock price prediction is 2.4690304710724 USD. The Axcella Health stock forecast is 2.4690304710724 USD for 2024 November 23, Saturday with technical analysis.

Icahn Enterprises L.P. (NASDAQ:IEP) posted its earnings results on Friday, November, 3rd. The conglomerate reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.34 by $0.35. The conglomerate had revenue of $2.99 billion for the quarter, compared to analysts' expectations of $2.71 billion.Web

3 Wall Street analysts have issued 1-year price objectives for Aurora Innovation's stock. Their AUR share price targets range from $1.75 to $7.00. On average, they anticipate the company's share price to reach $3.94 in the next twelve months. This suggests a possible upside of 79.8% from the stock's current price.Web

How have ONPH shares performed in 2023? Oncology Pharma's stock was trading at $0.3386 at the beginning of the year. Since then, ONPH shares have decreased by 99.9% and is now trading at $0.0002. View the best growth stocks for 2023 here.WebThe share price of Knightscope, Inc. Class A (KSCP) now. What analysts predict: $3.75. 52-week High/Low: $2.55 / $0.36. 50/200 Day Moving Average: $0.752 / $0.863. This figure corresponds to the Average Price over the previous 50/200 days. For Knightscope stocks, the 50-day moving average is the resistance level today.AXLA stock closed at $15.00 and is down -$0.96 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. AXLA has a roughly average overall score of 37 meaning the stock holds a better value than 37% of stocks at its current price.Axcella Health Inc. (AXLA) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. 2W 10W 9M. 4.5800 0.0000 (0.00%) At close: 04:00PM EST. 3.4200 -1.16 (-25.33%) After hours: 07:52PM EST.Name. Title. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a ...

View the latest American Axle & Manufacturing Holdings Inc. (AXL) stock price, news, historical charts, analyst ratings and financial information from WSJ.Predictions of AXLA stock price for tomorrow. StockInvest.us is a research service that provides financial data and technical analysis of publicly traded stocks.Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buyStock Price Forecast. According to 11 stock analysts, the average 12-month stock price forecast for NIO Inc. stock is $12.33, which predicts an increase of 72.45%. The lowest target is $8.00 and the highest is $18. …WebDec 1, 2023 · It is engaged in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism. The company's principal candidate consists of AXA1665 ... Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buy

AXLA Earnings Forecast. Next quarter’s earnings estimate for AXLA is -$1.25 with a range of -$1.25 to -$1.25. The previous quarter’s EPS was -$0.05. AXLA beat its EPS estimate …Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buy

Dec 1, 2023 · It is engaged in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism. The company's principal candidate consists of AXA1665 ... Nov 28, 2023 · Forecst.com predicts future values using technical analysis of a large number of analytical parameters. AXLA stock returns are also predicted based on historical data. According to our research, AXLA stock is a bad long-term investment. AXLA share price has been in a bear cycle for the past year. Axcella Health Inc. stock trend is negative . In 2028, AXLA is forecast to generate $69,153,277 in revenue, with the lowest revenue forecast at $69,153,277 and the highest revenue forecast at $69,153,277. If you're new to stock investing, here's how to buy Axcella Health stock .15 analysts have issued 12-month price objectives for Boeing's stock. Their BA share price targets range from $200.00 to $300.00. On average, they expect the company's stock price to reach $249.38 in the next year. This suggests a possible upside of 13.4% from the stock's current price.WebAxcella Health Inc Stock Price Forecast, "AXLA" Predictons for2024 Gas prices are at a record high, and experts are forecasting that prices could go higher this summer — perhaps $5 or even over $6 a gallon. By clicking "TRY IT", I agree to receive newsletters and promotions from Money and its partners. I a...We forecast stock performance using neural networks based on historical data. In our forecasting, we also use technical analysis tools and consider global geopolitical factors and news events. But remember that all forecast data on the site is provided for informational purposes for the use of neural forecasting tools in the …Exxe Group saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 5,000 shares, an increase of 900.0% from the October 15th total of 500 shares. Based on an average trading volume of 17,274,200 shares, the short-interest ratio is presently 0.0 days.

Axcella Health Inc (AXLA) Company Description. Axcella Health Inc a biotechnology company focused on treating complex diseases and improve health using endogenous metabolic modulator, or EMM, compositions. Its product candidates are comprised of multiple EMMs that are engineered in distinct combinations and ratios to simultaneously impact ...

Broker Rating. Only one brokerage firm provided a Hold-equivalent recommendation for Axcella Health Inc. This translates to an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 ...

Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company focused on pioneering a new approach to address the biology of complex diseases using compositions of endogenous metabolic modulators (EMMs), today announced that its Board of Directors has approved a 1-for-25 reverse stock split of the Company’s common stock.But as . Axcella Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst …8 Wall Street research analysts have issued 1-year target prices for Kura Oncology's shares. Their KURA share price targets range from $10.50 to $37.00. On average, they predict the company's share price to reach $27.31 in the next twelve months. This suggests a possible upside of 185.7% from the stock's current price.Nov. 02. MT. Wedbush Adjusts Axcella Health's Price Target to $6 From $9, Citing Stock Dilution; Outperform Rating Kept. 2022. MT. HC Wainwright Adjusts Axcella Health's Price Target to $10 From $8, Maintains Buy Rating. 2022. MT. More recommendations.10 equities research analysts have issued 1-year price objectives for Walgreens Boots Alliance's stock. Their WBA share price targets range from $21.00 to $45.00. On average, they anticipate the company's stock price to reach $29.36 in the next year. This suggests a possible upside of 41.2% from the stock's current price.What is AXLA's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors. This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...Dec 1, 2023 · A high-level overview of Axcella Health Inc. (AXLA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Stock price analysis for Axcella Health Inc. (AXLA), stock quote, stock research, rsi, macd, support, resistance and most important highlights. AXLA Axcella Health Inc. [AXLA] Stock ForecastStock Price Forecast. There is no forecast data available. Analyst Recommendations. There are no recommendations available. Earnings and Sales Forecasts. Current Quarter. Earnings per Share--Sales-- Axcella Health Inc (OTC:AXLA) Forecast: Price Targets, Revenue Estimate, Net Income Estimate, Operating Income & EBIT Estimate.

The Energous Corporation stock price gained 6.63% on the last trading day (Wednesday, 22nd Nov 2023), rising from $1.96 to $2.09. During the last trading day the stock fluctuated 18.09% from a day low at $1.88 to a day high of $2.22. The price has fallen in 6 of the last 10 days and is down by -18.2% for this period.In 2028, AXLA is forecast to generate $69,153,277 in revenue, with the lowest revenue forecast at $69,153,277 and the highest revenue forecast at $69,153,277. If you're new to stock investing, here's how to buy Axcella Health stock . NASDAQ:AXLA - Axcella Health Stock Price, News & Analysis Axcella Health Stock Price, News & Analysis (NASDAQ:AXLA) $1.00 0.00 (0.00%) (As of …Instagram:https://instagram. price on walmartatria stockbest volume indicatorsaofi stock Future criteria checks 0/6. Axcella Health's earnings are forecast to decline at 32.1% per annum while its annual revenue is expected to grow at 95.2% per year. EPS is expected to decline by 27.4% per annum. wisa technologythursday football news AXLA Earnings Forecast. Next quarter’s earnings estimate for AXLA is -$1.25 with a range of -$1.25 to -$1.25. The previous quarter’s EPS was -$0.05. AXLA beat its EPS estimate … russell 2000 value Nikola stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Nikola analysts is $ 2. Today 200 Day Moving Average is the resistance level (1.418 $). 50 Day Moving Average is the resistance level (1.2 $).7 Wall Street research analysts have issued 12 month price objectives for Energy Transfer's shares. Their ET share price targets range from $14.00 to $18.00. On average, they predict the company's share price to reach $16.50 in the next year. This suggests a possible upside of 20.6% from the stock's current price.Nov 30, 2023 · 11/29/2023. XPeng stock price stood at $16.61. According to the latest long-term forecast, XPeng price will hit $17 by the end of 2023 and then $20 by the end of 2024. XPeng will rise to $25 within the year of 2025, $30 in 2026, $35 in 2027, $45 in 2028, $50 in 2029, $55 in 2031, $60 in 2033 and $65 in 2034.